Sen. Ron Wyden (D-OR) with reporters in the Senate Subway (Graeme Sloan/Sipa via AP Images)

Top Wyden pri­or­i­ty for drug price re­forms: Medicare ne­go­ti­a­tions

As the Biden ad­min­is­tra­tion tries to wran­gle the de­tails of its in­fra­struc­ture bill, Sen­ate Fi­nance Com­mit­tee Chair Ron Wyden (D-OR) took a con­crete step for­ward on drug pric­ing re­forms on Tues­day and un­veiled five prin­ci­ples for such re­forms, in­clud­ing pro­vid­ing Medicare with the abil­i­ty to ne­go­ti­ate prices.

“Al­low­ing the Sec­re­tary of HHS to ne­go­ti­ate the price Medicare will pay cre­ates a much need­ed mech­a­nism to achieve fair­er prices when the mar­ket has failed to do so,” Wyden wrote.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.